Insufficient scRNA-seq data for expression of GPR55 at single-cell level.
Insufficient scRNA-seq data for expression of GPR55 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 548.44 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 511.71 | 900 / 929 | 0% | 0 | 0 / 0 |
lung | 67% | 31.23 | 388 / 578 | 12% | 0.22 | 134 / 1155 |
esophagus | 70% | 39.83 | 1005 / 1445 | 7% | 0.26 | 12 / 183 |
brain | 64% | 84.28 | 1687 / 2642 | 11% | 0.22 | 77 / 705 |
intestine | 57% | 99.90 | 554 / 966 | 16% | 0.52 | 83 / 527 |
skin | 43% | 17.80 | 785 / 1809 | 29% | 0.88 | 138 / 472 |
stomach | 63% | 34.43 | 227 / 359 | 9% | 0.21 | 26 / 286 |
lymph node | 0% | 0 | 0 / 0 | 62% | 2.73 | 18 / 29 |
bladder | 52% | 39.95 | 11 / 21 | 7% | 0.15 | 37 / 504 |
thymus | 21% | 10.97 | 139 / 653 | 34% | 1.00 | 204 / 605 |
prostate | 52% | 19.08 | 128 / 245 | 2% | 0.04 | 8 / 502 |
tonsil | 0% | 0 | 0 / 0 | 44% | 0.97 | 20 / 45 |
breast | 28% | 12.14 | 128 / 459 | 13% | 0.46 | 145 / 1118 |
kidney | 16% | 6.47 | 14 / 89 | 10% | 0.16 | 87 / 901 |
uterus | 14% | 3.55 | 24 / 170 | 10% | 0.25 | 48 / 459 |
adipose | 24% | 7.59 | 294 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 2% | 0.59 | 8 / 328 | 14% | 0.22 | 25 / 178 |
liver | 8% | 2.07 | 17 / 226 | 1% | 0.06 | 5 / 406 |
ovary | 3% | 0.64 | 5 / 180 | 5% | 0.08 | 21 / 430 |
adrenal gland | 6% | 1.40 | 16 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 5% | 1.91 | 69 / 1335 | 0% | 0 | 0 / 0 |
heart | 5% | 1.26 | 43 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.06 | 3 / 80 |
muscle | 0% | 0.04 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0038171 | Biological process | cannabinoid signaling pathway |
GO_0045453 | Biological process | bone resorption |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0004949 | Molecular function | cannabinoid receptor activity |
Gene name | GPR55 |
Protein name | G protein-coupled receptor 55 (cDNA FLJ75410, highly similar to Homo sapiens G protein-coupled receptor 55, mRNA) G protein-coupled receptor 55 G-protein coupled receptor 55 |
Synonyms | hCG_1645175 |
Description | FUNCTION: G-protein coupled receptor that binds to several ligands including 2-arachidonoyl lysophosphatidylinositol or lysophosphatidylglucoside with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways . Induces the Ca(2+) release from intracellular stores via ERK, the heterotrimeric G protein GNA13 and RHOA leading to morphological changes including cell rounding and stress fiber formation . In macrophages, acts downstream of lysophosphatidylglucoside to inhibit the translocation of the phospholipid-transporting ABCA1 to plasma membrane and subsequent cholesterol efflux leading to lipid accumulation and foam cell formation . . |
Accessions | ENST00000650999.1 ENST00000392039.2 ENST00000444078.5 Q9Y2T6 ENST00000392040.5 ENST00000622008.4 ENST00000438398.1 C9J1P7 A8K858 |